POLRMT and colorectal carcinoma: Furthermore, the POLRMT inhibitor impeded cell proliferation, as demonstrated by reduced nuclear EdU incorporation (Fig. 3L), and inhibited in vitro cell migration (Fig. 3M) in the CRC cells.